440 Trastuzumab For Injection

Name: 440 Trastuzumab For Injection
Brand: NEETCO BIOPHARMA
Price: 17999 INR
Availability: InStock

Price 17999 INR/ Box

Get a Price/Quote

MOQ : 1 Box

440 Trastuzumab For Injection Specification

Dosage Form
For Injection

Salt Composition
Trastuzumab Lyophilized Powder

Indication
Metastatic Breast Cancer, Gastric Cancer

Enzyme Types
Monoclonal Antibody (not enzyme)

Feature
Highly purified monoclonal antibody targeting HER2 protein

Ingredients
Trastuzumab, Excipients

Application
Intravenous infusion for cancer treatment

Ph Level
Neutral pH (typically 6.07.0 in reconstituted solution)

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Not applicable (monoclonal antibody)

Storage Instructions
Store at 28C, protect from light, do not freeze

Shelf Life
24 months

Reconstitution Solvent
Sterile Water for Injection

Packing Type
Single vial with carton packaging

Strength
440 mg per vial

Compatibility
Do not mix with other drugs in same IV line

Administration Route
Intravenous

Usage Precaution
For hospital or clinical use only, under physician supervision

Container Material
Medical Grade Glass

Registration
CDSCO/WHO-GMP approved

Expiry Details
Marked on label and carton

Intended Patient Group
Adults with confirmed HER2-positive tumors

Marketed By
Licensed Oncology Pharmaceuticals Company

Batch Number
Available on carton

Product Code
TRZ440

Clinical Trials
Backed by large scale multicenter studies

About 440 Trastuzumab For Injection

440 Trastuzumab For Injection offers an extraordinary solution for adults with HER2-positive metastatic breast or gastric cancer. Redeem the benefits of a first-class treatment, uniquely designed using a highly purified monoclonal antibody, Trastuzumab. Personalise your treatment strategy with this premium, hospital-grade medication, which is administered intravenously and reconstituted with sterile water. Take advantage of its CDSCO/WHO-GMP approval, odorless formulation, neutral pH, and compatibility guidelines. Housed in medical-grade glass, this product is perfect for licensed clinical environments, ensuring efficacy, safety, and reliability for oncology professionals and patients alike.

Premier Monoclonal Antibody Therapy with Distinct Advantages

440 Trastuzumab For Injection stands out as a first-class choice for HER2-positive cancer therapy, backed by large-scale multicenter clinical trials. Its neutral pH and highly purified monoclonal antibody ensure safety and efficacy. Competitive advantages include CDSCO/WHO-GMP certification and advanced, medical-grade glass packaging. Application areas extend across major oncology centers, clinical research institutes, and specialized hospitals, making it perfect for handling both metastatic breast and gastric cancer cases with confidence.

Certified Sample Access and Smooth Goods Transport Experience

Experience the premium service of sample availability for 440 Trastuzumab, ensuring that clinical settings can verify quality before bulk procurement. Shipped goods are monitored for temperature control, ensuring preservation of potency and stability throughout transport. All products are dispatched from certified and licensed suppliers, delivering international-standard pharmaceuticals with relevant certifications such as CDSCO and WHO-GMP. Flexible payment terms are available, making transactions straightforward and securing your hospital's access to world-class cancer therapy.

FAQ's of 440 Trastuzumab For Injection:

Q: How should 440 Trastuzumab For Injection be administered for optimal results?

A: This medication is designed for intravenous infusion, following reconstitution with sterile water for injection. Administration should only be performed by healthcare professionals in a hospital or clinical setting under strict physician supervision.

Q: What clinical benefits does this product offer for cancer patients?

A: 440 Trastuzumab targets the HER2 protein on cancer cells, helping to inhibit tumor growth specifically for HER2-positive metastatic breast and gastric cancer patients. It is supported by extensive multicenter clinical trials, ensuring proven effectiveness and safety.

Q: When is it appropriate to consider 440 Trastuzumab For Injection in therapy?

A: The product is intended for use in adults diagnosed with confirmed HER2-positive metastatic breast or gastric cancer, as part of a comprehensive cancer treatment plan decided by an oncologist.

Q: Where can healthcare providers source this first-class oncology product?

A: Licensed hospitals, clinics, and authorized distributors in India and globally can obtain 440 Trastuzumab For Injection from registered suppliers and exporters with proper certifications and established reputation.

Q: What precautions must be taken during preparation and administration?

A: Do not mix 440 Trastuzumab with other drugs in the same IV line, and always reconstitute with sterile water. Store the reconstituted vial at 2-8C, protect it from light, and never freeze. Usage is restricted to clinical environments.

Q: How can buyers access product sample and certification details?

A: Samples can be requested from verified distributors. All shipped goods come with complete batch information, expiry, and CDSCO/WHO-GMP certification documents, ensuring compliance and quality assurance.

Tell us about your requirement